Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dynein regulatory complex subunit 11 (DRC11) is a structural and regulatory protein in the nexin–dynein regulatory complex (N-DRC), an essential macromolecular assembly in motile cilia and flagella[3]. DRC11 contains a calmodulin-binding motif and an AAA domain, suggesting roles in calcium-mediated signaling and ATP-dependent structural rearrangements. DRC11, together with DRC8, forms a subcomplex in the proximal lobe of the N-DRC linker domain, facilitating contacts to the neighboring B-tubule and modulating ciliary bending and beat regulation[3][1]. Loss of DRC11 disrupts assembly of DRC8, destabilizes N-DRC structure, and reduces ciliary motility, with implicated roles in clinical ciliopathies such as primary ciliary dyskinesia. DRC11 is not an enzyme, receptor, ion channel, or transporter, but is integral to the architecture and dynamics of axonemal microtubules[3].
Not applicable; there are no drugs known to act on DRC11.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dynein regulatory complex subunit 11 (DRC11).